Text

How gut bacteria and diet can weaken cancer treatments

Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.

Tracking mouth bacteria may predict childhood cavities before they start

Tracking the oral microbiota can help identify ECC risk early and inform prevention strategies in children, even before visible signs of decay.

Targeting gut bacteria with acetate offers new hope for treating obesity

AceCel is a promising way to help manage obesity by targeting gut bacteria and metabolism together.

The gut-brain axis and the role of the intestinal barrier

The science behind gut-brain communication and the role of intestinal integrity.

A Day in 2045: Paying Your Rent with Microbial Credits

What if in 2045 you could pay rent with microbes? Discover a future where microbial credits become the new currency.

‘Trojan horse’ nanoparticles target cancer and bacteria to boost cancer therapy

Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.

The gut microbiota impacts female infertility

Women with lower DI-GM scores showed a higher risk of infertility, highlighting the potential importance of gut microbiota diversity as a factor in female reproductive health.

Microbiome milestone: MaaT Pharma and Clinigen team up to deliver innovative oncology therapy

Xervyteg® marks a major advance in microbiome therapeutics, with potential to become the first approved microbiota therapy in Europe.

A gut fungus may help protect against advanced liver disease

Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.

Study reveals how skin bacteria establish and persist over time

Certain barriers on the skin prevent easy colonization of new strains and specific life stages, such as adolescence, may be crucial for successful probiotic interventions.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top